# FDA recall D-0002-2020

> **Pfizer Inc.** · Class III · drug recall initiated 2019-09-12.

## Product

Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24

## Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date.  The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0002-2020
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-09-12
- **Report date:** 2019-10-02
- **Termination date:** 2023-04-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0002-2020

## Citation

> AI Analytics. FDA recall D-0002-2020. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-0002-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*